[LGND] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
14-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- 647.94%
YoY- -80.68%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 21,192 22,998 14,737 13,635 12,936 3,940 13,977 7.17%
PBT 5,826 7,012 2,008 950 5,997 -1,587 1,034 33.37%
Tax -515 279 139 -1,636 495 -3,935 -1,535 -16.63%
NP 6,341 7,055 1,869 1,063 5,502 4,503 3,036 13.05%
Tax Rate 8.84% -3.98% -6.92% 172.21% -8.25% - 148.45% -
Total Cost 14,851 15,943 12,868 12,572 7,434 -563 10,941 5.22%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 29.92 30.68 12.68 7.80 42.53 114.29 21.72 5.48%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS 0.32 0.35 0.09 0.05 0.28 0.23 0.16 12.24%
EPS Diluted 0.29 0.34 0.09 0.05 0.28 0.23 0.16 10.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.